New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management

作者：St Peter Wendy L^*; Wazny Lori D; Patel Uptal D

来源：Current Opinion in Nephrology and Hypertension, 2013, 22(6): 656-662.

DOI：10.1097/MNH.0b013e328365b364

• chronic kidney disease
• healthcare models
• medication therapy management
• pharmacists

Purpose of reviewPatients with chronic kidney disease (CKD) are complex, have many medication-related problems (MRPs) and high rates of medication nonadherence, and are less adherent to some medications than patients with higher levels of kidney function. Nonadherence in CKD patients increases the odds of uncontrolled hypertension, which can increase the risk of CKD progression. This review discusses reasons for gaps in medication-related care for CKD patients, pharmacy services to reduce these gaps and successful models that incorporate pharmacist care.Recent findingsPharmacists are currently being trained to deliver patient-centred care, including identification and management of MRPs and helping patients overcome barriers to improve medication adherence. A growing body of evidence indicates that pharmacist services for CKD patients, including medication reconciliation and medication therapy management, positively affect clinical and cost outcomes, including lower rates of decline in glomerular filtration rates, reduced mortality and fewer hospitalizations and hospital days, but more robust research is needed. Team-based models including pharmacists exist today and are being studied in a wide range of innovative care and reimbursement models.SummaryOpportunities are growing to include pharmacists as integral members of CKD and dialysis healthcare teams to reduce MRPs, increase medication adherence and improve patient outcomes.

• 出版日期2013-11